The pahtway p1405 has 69 genes in the original annotation. Currently, there are 43 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
|
| Gene ID |
Symbol |
Synonyms |
Official Full Name |
Start Site |
End Site |
Location |
| 59 | ACTA2 | AAT6 | ACTSA | MYMY5 | actin, alpha 2, smooth muscle, aorta | | | 10q23.3 |
| 10580 | SORBS1 | CAP | FLAF2 | R85FL | SH3D5 | SH3P12 | SORB1 | sorbin and SH3 domain containing 1 | | | 10q23.33 |
| 51700 | CYB5R2 | B5R.2 | cytochrome b5 reductase 2 | | | 11p15.4 |
| 7704 | ZBTB16 | PLZF | ZNF145 | zinc finger and BTB domain containing 16 | | | 11q23.1 |
| 23705 | CADM1 | BL2 | IGSF4 | IGSF4A | NECL2 | Necl-2 | RA175 | ST17 | SYNCAM | TSLC1 | sTSLC-1 | sgIGSF | synCAM1 | cell adhesion molecule 1 | | | 11q23.2 |
| 6876 | TAGLN | SM22 | SMCC | TAGLN1 | WS3-10 | transgelin | | | 11q23.2 |
| 4256 | MGP | GIG36 | MGLAP | NTI | matrix Gla protein | | | 12p12.3 |
| 2353 | FOS | AP-1 | C-FOS | p55 | FBJ murine osteosarcoma viral oncogene homolog | | | 14q24.3 |
| 23336 | SYNM | DMN | SYN | synemin | | | 15q26.3 |
| 4629 | MYH11 | AAT4 | FAA4 | SMHC | SMMHC | myosin, heavy chain 11, smooth muscle | | | 16p13.11 |
| 6376 | CX3CL1 | ABCD-3 | C3Xkine | CXC3 | CXC3C | NTN | NTT | SCYD1 | fractalkine | neurotactin | C-X3-C motif chemokine ligand 1 | | | 16q13 |
| 1264 | CNN1 | HEL-S-14 | SMCC | Sm-Calp | calponin 1 | | | 19p13.2 |
| 1675 | CFD | ADIPSIN | ADN | DF | PFD | complement factor D (adipsin) | | | 19p13.3 |
| 2354 | FOSB | AP-1 | G0S3 | GOS3 | GOSB | FBJ murine osteosarcoma viral oncogene homolog B | | | 19q13.32 |
| 26289 | AK5 | AK6 | adenylate kinase 5 | | | 1p31 |
| 199920 | C1orf168 | - | chromosome 1 open reading frame 168 | | | 1p32.2 |
| 59269 | HIVEP3 | KBP-1 | KBP1 | KRC | SHN3 | Schnurri-3 | ZAS3 | ZNF40C | human immunodeficiency virus type I enhancer binding protein 3 | | | 1p34 |
| 5174 | PDZK1 | CAP70 | CLAMP | NHERF-3 | NHERF3 | PDZD1 | PDZ domain containing 1 | | | 1q21 |
| 477 | ATP1A2 | FHM2 | MHP2 | ATPase Na+/K+ transporting subunit alpha 2 | | | 1q23.2 |
| 467 | ATF3 | - | activating transcription factor 3 | | | 1q32.3 |
| 1827 | RCAN1 | ADAPT78 | CSP1 | DSC1 | DSCR1 | MCIP1 | RCN1 | regulator of calcineurin 1 | | | 21q22.12 |
| 84417 | C2orf40 | ECRG4 | chromosome 2 open reading frame 40 | | | 2q12.2 |
| 79781 | IQCA1 | 4930465P12Rik | DRC11 | IQCA | IQ motif containing with AAA domain 1 | | | 2q37.3 |
| 152015 | ROPN1B | - | rhophilin associated tail protein 1B | | | 3q21.2 |
| 57205 | ATP10D | ATPVD | ATPase phospholipid transporting 10D (putative) | | | 4p12 |
| 125 | ADH1B | ADH2 | HEL-S-117 | alcohol dehydrogenase 1B (class I), beta polypeptide | | | 4q23 |
| 2690 | GHR | GHBP | GHIP | growth hormone receptor | | | 5p13-p12 |
| 1452 | CSNK1A1 | CK1 | CK1a | CKIa | HEL-S-77p | HLCDGP1 | PRO2975 | casein kinase 1 alpha 1 | | | 5q32 |
| 2568 | GABRP | - | gamma-aminobutyric acid type A receptor pi subunit | | | 5q35.1 |
| 7754 | ZNF204P | ZNF184-Lp | ZNF204 | ZNF315P | b24o18.1 | zinc finger protein 204, pseudogene | | | 6p21.3 |
| 3400 | ID4 | IDB4 | bHLHb27 | inhibitor of DNA binding 4, HLH protein | | | 6p22.3 |
| 60468 | BACH2 | BTBD25 | BTB domain and CNC homolog 2 | | | 6q15 |
| 857 | CAV1 | BSCL3 | CGL3 | LCCNS | MSTP085 | PPH3 | VIP21 | caveolin 1 | | | 7q31.1 |
| 5764 | PTN | HARP | HBGF8 | HBNF | NEGF1 | pleiotrophin | | | 7q33 |
| 6422 | SFRP1 | FRP | FRP-1 | FRP1 | FrzA | SARP2 | secreted frizzled-related protein 1 | | | 8p11.21 |
| 51050 | PI15 | CRISP8 | P24TI | P25TI | peptidase inhibitor 15 | | | 8q21.11 |
| 55074 | OXR1 | Nbla00307 | TLDC3 | oxidation resistance 1 | | | 8q23 |
| 4781 | NFIB | CTF | HMGIC/NFIB | NF-I/B | NF1-B | NFI-B | NFI-RED | NFIB2 | NFIB3 | nuclear factor I/B | | | 9p24.1 |
| 256691 | MAMDC2 | - | MAM domain containing 2 | | | 9q21.12 |
| 301 | ANXA1 | ANX1 | LPC1 | annexin A1 | | | 9q21.13 |
| 4915 | NTRK2 | GP145-TrkB | TRKB | trk-B | neurotrophic tyrosine kinase, receptor, type 2 | | | 9q22.1 |
| 4128 | MAOA | MAO-A | monoamine oxidase A | | | Xp11.3 |
| 2824 | GPM6B | M6B | glycoprotein M6B | | | Xp22.2 |